Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 43–43 | Cite as

Antineoplastics

Various toxicities: case report
Case report
  • 32 Downloads

Reference

  1. Guan J, et al. Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. Cold Spring Harbor Molecular Case Studies 4: a002550, No. 4, Aug 2018. Available from: URL: http://doi.org/10.1101/mcs.a002550 - Sweden

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations